Literature DB >> 17613761

Association between Epstein-Barr virus and Hodgkin's lymphoma in Belgium: a pathological and virological study.

Mounir Trimèche1, Christophe Bonnet, Sadok Korbi, Jacques Boniver, Laurence de Leval.   

Abstract

The association between Epstein-Barr virus (EBV) and classical Hodgkin's lymphoma (cHL) varies according to the geographic location. In this work we sought to characterize EBV involvement in a series of 111 cHL cases diagnosed in Belgium. The overall prevalence of EBV infection detected by in situ hybridization in Reed-Sternberg cells was 33%. EBV positivity correlated with older age at diagnosis (>54 years; p = 0.01), mixed cellularity subtype (p = 0.000001), male gender (p = 0.004) and tended to be associated with higher clinical stage (III/IV; p = 0.02). The molecular features of the virus in EBV-positive cHL were studied by comparison with a series of reactive tonsils. A 30-bp deletion within the LMP-1 gene was in 15/28 (53.6%) EBV-positive cHL cases, and in 41.7% of reactive tonsil samples. This variant did not correlate with any clinical or pathological feature. The EBV strain was type A in all cHL and reactive samples.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613761     DOI: 10.1080/10428190701411177

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

1.  Epstein-Barr virus and Hodgkin's lymphoma in Cairo, Egypt.

Authors:  Josée Audouin; Jacques Diebold; Bharat Nathwani; Elia Ishak; Kenneth Maclennan; Hans Konrad Mueller-Hermelink; James O Armitage; Dennis D Weisenburger
Journal:  J Hematop       Date:  2010-05-28       Impact factor: 0.196

Review 2.  The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.

Authors:  Cindy M Chang; Kelly J Yu; Sam M Mbulaiteye; Allan Hildesheim; Kishor Bhatia
Journal:  Virus Res       Date:  2009-07-23       Impact factor: 3.303

3.  H pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression.

Authors:  Valeska Portela Lima; Marcos Antonio Pereira de Lima; Angela Rosa André; Márcia Valéria Pitombeira Ferreira; Marcos Aurélio Pessoa Barros; Sílvia Helena Barem Rabenhorst
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

4.  Impact of Tumour Epstein-Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL.

Authors:  Mahdi Nohtani; Katerina Vrzalikova; Maha Ibrahim; Judith E Powell; Éanna Fennell; Susan Morgan; Richard Grundy; Keith McCarthy; Sarah Dewberry; Jan Bouchal; Katerina Bouchalova; Pamela Kearns; Paul G Murray
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

5.  A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma.

Authors:  Fu-Tuo Feng; Qian Cui; Wen-Sheng Liu; Yun-Miao Guo; Qi-Sheng Feng; Li-Zhen Chen; Miao Xu; Bing Luo; Da-Jiang Li; Li-Fu Hu; Jaap M Middeldorp; Octavia Ramayanti; Qian Tao; Su-Mei Cao; Wei-Hua Jia; Jin-Xin Bei; Yi-Xin Zeng
Journal:  Chin J Cancer       Date:  2015-12-16

6.  Prevalence of Epstein–Barr Virus Genotypes in Pakistani Lymphoma Patients

Authors:  Sadia Salahuddin; Jabbar Khan; Joharia Azhar; Christopher B. Whitehurst; Ishtiaq Qadri; Julia Shackelford; Joseph S Pagano; Dost Muhammad; Kristy L Richards
Journal:  Asian Pac J Cancer Prev       Date:  2018-11-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.